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Abstract 
It is believed that the bitter taste of amoxicillin, an antibiotic drug is due to its amino group. 
Hence, it is expected that blocking the amino group with a suitable linker could inhibit the 
interaction between amoxicillin and its bitter taste receptor/s and hence masking the bitter taste 
of the drug. Part of this thesis will shed light on the use of molecular orbital methods such as 
Using Density Functional Theory, and ab initio for the design of novel prodrugs. This novel 
prodrug approach implies prodrug design based on enzyme models that were utilized for 
mimicking enzyme catalysis. The computational approach exploited for the prodrug design 
involves molecular orbital and molecular mechanics calculations and correlations between 
experimental and calculated values of intramolecular processes that were experimentally studied 
to assign the factors affecting the reaction rates in certain processes for better understanding on 
how enzymes might exert their extraordinary catalysis. 
Using Density Functional Theory and ab initio calculations, intramolecular proton transfer 
reaction in Kirby‘s enzyme models on an intramolecular acid catalyzed hydrolysis of N-
alkylmaleamic (4-amino-4-oxo-2-butenoic) acids (Kirby‘s N-alkylmaleamic acids) revealed that 
the reaction rate is largely dependent on the distance between the two reactive centers (rGM), the 
attack angle (α) and the strain energy. The rate of the reaction is linearly correlated with rGM
2
, sin 
(180
◦
-α), and the strain energy. The calculations demonstrated that the amide bond cleavage is 
due to intramolecular nucleophilic catalysis by the adjacent carboxylic acid group and the rate-
limiting step is determined based on the nature of the amine leaving group. 
Hence, the calculations provide a conceivable basis for designing amoxicillin prodrugs for 
masking bitter taste of the corresponding parent drugs, which have the potential to release the 
drug in a controlled release fashion. In addition, a linear correlation of the calculated values has 
drawn credible basis for designing amoxicillin prodrugs that are bitterless, and stable in neutral 
aqueous solutions, also the intra-conversion rates of the amoxicillin prodrugs to amoxicillin can 
be programmed according to the nature of the prodrug linker. Based on the calculated B3LYP/6-
31 G (d,p) rates, high rates were  predicted for ProD4 and ProD5 compared with ProD1, ProD2 
and ProD3. 
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Chapter one 
Introduction  
1.1 Background 
The acceptable taste of the active ingredient of a drug is a significant obstacle in developing a 
patient friendly dosage form. It is a key issue for doctors and pharmacists administering the 
drugs especially for the pediatric and geriatric populations. Organoleptic properties, such as 
taste, are an important factor when selecting a certain drug from the generic products available 
on the market that have the same active ingredient [1]. 
The past sixty years have seen an increasing number of chemists, biochemists, biologists and 
other researchers in various fields who use computational methods for better understanding of 
the mechanism of organic reactions and biochemical processes for predicting active biological 
molecules and for calculating the molecular properties of a new drug candidate [2]. 
Computational chemistry is the application of chemical, mathematical and computing skills to 
assist in solving chemical problems. The term computational chemistry is mainly used when 
developing a mathematical method so it can be automated for implementation on a computer.  It 
uses computers to generate information such as properties of molecules or simulated 
experimental results. Recently, computational chemistry was utilized to improve solubility, 
stability and bioavailability of drugs and also to mask their bitter taste [3].  
Most of the computational chemistry scientists' use based on Schrodinger equation; this is 
because the Schrodinger equation models the atoms and molecules with mathematics and it gives 
information about: 
 Geometry optimizations. 
 Frequency calculations. 
 Protein calculations, i.e. docking. 
 Electron and charge distributions. 
 Potential energy surfaces (PES). 
 Rate constants for chemical reactions (kinetics). 
 Thermodynamic calculations- heat of reactions, energy of activation. 
 Electronic structure. 
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 Transition structures. 
1.2 The use of computational chemistry in drug design 
 
Computational chemistry is used in many different ways. One particularly important way is in 
understanding physical or chemical problems more completely. There are some properties of a 
molecule that can be obtained computationally and more easily than by experiment. It also gives 
information about molecular bonding that cannot be obtained from any experimental method. A 
second use of computational chemistry is to model a molecular system before synthesizing that 
molecule in the laboratory, and helps chemists to make predictions before running the actual 
experiments so that they can be better prepared for making observations [4]. It uses the 
theoretical chemistry results, links them into efficient computer programs, and calculates the 
structures physical and chemical properties of molecules [3]. This is very useful information 
because synthesizing a single compound could require months of labor and raw materials, and 
generate toxic waste. The design and synthesis of prodrugs were based on intramolecular 
processes utilizing molecular orbital methods and correlations between experimental and 
calculated values, thus many experimental chemists are now using computational design to gain 
additional understanding of the compounds being examined in the laboratory [1]. 
Currently, there are two ways to approach chemistry problems: computational quantum 
chemistry and non-computational quantum chemistry. 
 Computational quantum chemistry is mainly concerned with the numerical 
computation of molecular electronic structures by ab initio and semi-empirical 
techniques. 
 Non-computational quantum chemistry concerned with the analytical expressions 
for the properties of molecules and their reactions. 
 
Today the quantum mechanics (QM) such as ab initio, semi-empirical and density functional  
theory (DFT), and molecular mechanics (MM) are mainly being used and broadly accepted as 
precise tool for providing structure – energy calculations for drugs and prodrugs [3]. Definitions 
of these terms are useful in understanding the use of computational techniques for chemistry.  
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1.2.1 Quantum mechanics (QM) 
QM is the correct mathematical description of the behavior of electrons and thus of chemistry. In 
reactions, quantum chemistry studies the ground state of individual atoms and molecules, the 
excited states, and the transition states that occur during chemical reactions. 
 It involves heavy interplay of experimental and theoretical methods: 
 In theory, QM can predict the property of an individual atom or molecule in an exact 
manner.  
 In practice, the QM equations have only been solved exactly for one electron systems. A 
myriad collection of methods has been developed for approximating the solution for 
multiple electron systems.  
The quantum mechanics includes: (1) Ab-initio (2) Semi-empirical (3) DFT methods. 
 
1.2.1.1 Ab initio Methods 
 
The term ab initio is Latin for ``from the beginning''. Ab initio quantum chemistry has become 
very important tool in the study of atoms and molecules and in modeling complex systems such 
as those arising in biology [1]. Ab initio methods typically are adequate only for small systems 
that are based entirely on theory from first principles. The ab initio molecular orbital methods 
(QM) are based mainly on the Schrodinger equation, given the positions of a collection of atomic 
nuclei, and the total number of electrons in the system, energy, electron density, and calculates 
the electronic properties by means of a well-defined, automated approximation. The advantage of 
ab initio electronic structure methods that they can be made to converge to the exact solution, 
when all approximations are sufficiently small in magnitude. The disadvantage of ab initio 
methods is their enormous computational cost; they take a significant amount of computer 
memory, time, and disk space [5].  
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1.2.1.2 Semi-empirical Methods 
 
The semi-empirical quantum chemistry method is based on the Hartree–Fock formalism. Within 
this framework, certain pieces of information are approximated or completely excluded. Usually, 
the core electrons are not included in the calculation and only a minimal basis set is used. In 
order to correct for the errors introduced by omitting part of the calculation, the method is 
parameterized. Parameters help to estimate the omitted values and they are obtained by 
comparing the results to ab initio calculations or experimental data. Often, these parameters 
replace some of the integrals that are excluded [6]. 
The advantage of the semi empirical calculations is that they are much faster than ab initio 
calculations and their disadvantage is that the results can be unpredictable and fewer properties 
can be predicted reliably. If the molecule being computed is similar to molecules in the database 
used to parameterize the method, and then the results may be very good. If the molecule being 
computed is significantly different from anything in the parameterization set, the answers may be 
very poor [1]. 
Semi-empirical methods are MINDO, MNDO, MINDO/3, AM1, PM3 and SAM1. Calculations 
of molecules containing up to100 atoms can be done using semi-empirical methods [6]. 
 
1.2.1.3 Density functional theory (DFT) 
 
Density functional theory (DFT) is a computational quantum mechanical modeling method used 
in chemistry to investigate the electronic structure (principally the ground state) of many-body 
systems, in particular atoms, molecules. DFT has become very popular in recent years, this is 
justified based on the pragmatic observation that it is less computationally intensive than other 
methods with similar accuracy [7]. 
Using DFT method the energy of a molecule can be obtained from the electron density using 
functions that is functions of another function. This theory raised up with a theorem by Hoe burg 
and Kohn [8]. 
The DFT method is suitable for calculating energies and structures for medium-sized systems 
(30-60 atoms) of biological, medicinal, and pharmaceutical interest. 
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The use of DFT method become larger, however some difficulties when 
describing intermolecular interactions still encountered, especially transition states, van deer 
Waals forces (dispersion); charge transfer excitations;, global potential energy surfaces, and 
incomplete treatment of dispersion can adversely affect the DFT degree of accuracy in the 
treatment of systems which are govern by dispersion [7]. 
 
1.2.2 Molecular Mechanics 
 
Molecular mechanics is a mathematical approach used for the computation of energy, structures, 
dipole moment, and other physical properties. It is mainly used in calculating many diverse 
biological and chemical systems such as large crystal structures, proteins, and relatively large 
solvated systems. However, this method is limited by the determination of parameters such as the 
large number of unique torsion angles [9]. 
Molecular mechanics simulations, for example, use a single classical expression for the energy 
of a compound. The database of compounds used for parameterization, i.e., the resulting set of 
parameters and functions is called the force field. A force field parameterized against a specific 
class of molecules, for example proteins, would be expected to only have relevance when 
describing other molecules of the same class. These methods can be applied to large biological 
molecules and proteins, and allow studies of the approach and docking of potential drug 
molecules. The treatment of large, condensed-phase systems (e.g., proteins in aqueous solution) 
entirely by ab initio methods is very expensive computationally and if a molecule is so big that a 
semi-empirical treatment cannot be used efficiently, it is still possible to model its behavior 
avoiding quantum mechanics totally by using molecular mechanics. However, it is often the case 
that a relatively small region of the system can be modeled at the ab initio quantum chemical 
level, whereas the rest of the system can be treated more approximately by means of molecular 
mechanics (MM). The technologies for coupling quantum chemical methods to these alternative 
types of models, mixed quantum mechanics (QM)/MM) have become an important component 
of the theoretical arsenal, enabling realistic modeling of the most complex molecular structures 
[1]. 
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1.3 Amoxicillin 
Amoxicillin is (2S,5R,6R)-6-{(E)-[(2R)-2-Amino-1-hydroxy-2-(4-
hydroxyphenyl)ethylidene]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-
carboxylic acid, As shown in (Fig. 1) with a molecular weight of 365.4 g/mol. and molecular 
formula of  C16H19N3O5S. 
 
 
 
Figure 1: Chemical structure of amoxicillin. 
 
 It is the drug of choice within its class because it is well absorbed following oral administration. 
Amoxicillin is the mostly common antibiotic prescribed for children. It has high absorption after 
oral administration, which is not altered and affected by the presence of food. Amoxicillin dose 
reaches Cmax about 2 hours after administration and is quickly distributed, and eliminated by 
excretion in urine (about 60%- 75%). The antibacterial effect of amoxicillin is prolonged by the 
presence of a benzyl ring in the side chain. Because amoxicillin is susceptible to degradation by 
β-lactamases-producing bacteria, which are resistant to a broad spectrum of β-lactam antibiotics, 
such as penicillin, for this reason, it is often combined with clavulanic acid, a β-lactamase 
inhibitor. This increases effectiveness by reducing its susceptibility to β-lactamase resistance. 
Amoxicillin has two ionizable groups in the physiological range (the amino group in α-position 
to the amide carbonyl group and the carboxyl group). Amoxicillin has a good pharmacokinetics 
profile with bioavailability of 95% if taken orally, its half-life is 61.3 minutes and it is excreted 
by the renal and less than 30 % bio-transformed in the liver [9-12].    
 
 
 
8 
 
1.4 Research problem 
 
Amoxicillin have extremely unpleasant and bitter taste, which is difficult to mask. This creates a 
serious problem in pediatric and geriatric patients. Even though, the strategies that were used for 
masking bitter taste by the use of sweeteners and flavors may cause a serious problem in diabetic 
pediatrics and geriatrics patients. Amoxicillin bitter taste sensation is the result of the hydrogen 
bonding between the free amino groups of the drug with the active site of the bitter taste 
receptors on the tongue. Designing a prodrug promoiety with a suitable linker could reduce or 
eliminate their bitterness by altering the ability of the drug to interact with their bitter taste 
receptors; this could be obtained by an appropriate modification of the structure and the size of 
the bitter compound. We believe that blocking the amine group in amoxicillin by making the 
proposed prodrugs may result in inhibition of the interaction between the amine group of the 
antibacterial agent and the bitter taste receptors and hence masking its bitterness. 
 
The major problems in the administration of amoxicillin antibacterial drug: 
 
1) Their bitter taste, which leads to lack of patient compliance and might create a serious 
challenge to the pharmacist in pediatric and geriatric formulations. 
2) Synthesis of prodrugs, which have the potential to release the parental drugs in a controlled 
manner, have a good chance to overcome the frequent dosing problem. 
 
1.5 Thesis Objectives 
 
1.5.1 General objectives 
 
The main goal of this research was to design prodrugs lacking any bitter or unpleasant sensation 
and having the potential to release their parent drugs in a controlled manner, using a variety of 
different molecular orbital and molecular mechanics methods and correlations between 
experimental and calculated reactions rates, five novel antibacterial prodrugs of amoxicillin were 
designed. 
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1.5.2 Specific objectives 
 
►Calculations of Kirby‘s enzyme model mechanism for the design of amoxicillin prodrugs, 
which should have the following properties: 
 Lack of bitter taste. 
 Have a modified hydrophilic-lipophilic balance (HLB) value. 
 To furnish upon cleavage a safe and non-toxic by-products. 
 To release the parental drug in controlled manner. 
 
1.6 Research questions 
 
 Would the DFT calculations be good methods for the design of amoxicillin prodrugs that 
have the potential to mask the bitterness of the active drugs and be cleaved in 
physiological environments to furnish the active drugs in a programmable manner and a 
non-toxic moiety? 
 Would the DFT and ab initio methods are capable of producing reaction rates similar to 
that obtained by Kirby? 
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Literature review 
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Chapter two 
2.1 Literature Review 
Bitter or unpleasant taste is a major problem in the food and medicine industries;  amoxicillin 
has an extremely unpleasant and bitter taste which is difficult to mask. Taste become altered as a 
function of the aging process, which explains why most children find certain flavors to be too 
strong when adults do not, and they have larger number of taste buds than adults, which are 
responsible for sensitivity toward taste. Different approaches are commonly utilized to overcome 
bitter and unpleasant taste of drugs. This includes reduction of drug solubility in saliva, where a 
balance between bioavailability and reduced solubility must be achieved. But these approaches 
could not overcome the problem of bitterness [13].  
Bitter molecules bind to G-protein coupled receptor-type T2R on the apical membrane of the 
taste receptor cells located in the taste buds on the tongue to give bitter, sweet or other taste 
sensations. Altering the ability of the drug to interact with taste receptors could reduce or 
eliminate their bitterness. This could be achieved by a suitable modification of the size and the 
structure of a bitter compound [14,15]. 
Amoxicillin generally suffers bitter taste sensation. Through many research approaches, the 
prodrug approach has been widely used for the development of drugs delivery to their site of 
action by physicochemical modulation that affect absorption or by targeting to specific enzymes 
or membrane transporters. Among these, various approaches that are used in order to minimize 
the undesirable properties of the drug while retaining the desirable therapeutic activity, the 
prodrug approach. This approach can be useful in the optimization of the clinical application of 
most of the drugs [16,17]. 
The new novel chemical approach involves the design of prodrugs for masking bitter taste based 
on intramolecular processes using DFT and ab initio methods and correlations of experimental 
and calculated reactions rates. In this approach, no enzyme is needed to catalyze the 
interconversion of a prodrug to its corresponding drug. The rate of drug release is controlled by 
the nature of the linker bound to the bitter drug. The role of the linker is to block the free amine 
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group in the corresponding parental drug and to convert it into the more stable amide group; the 
former is believed to be responsible for the bitterness of the drug [18]. 
 
Using computational chemistry numerous enzyme models were established for determining the 
reaction mechanism in order to investigate the driving force affecting the reaction rate for design 
an efficient prodrug capable of releasing the parental drug in a controlled manner. In which the 
promoiety can be covalently linked to a parent drug to result in chemically and not enzymatically 
cleavage upon exposure to physiological environment [19]. 
 
2.2 Enzyme catalysis 
Enzymes are essential for the interconversion of many prodrugs to their active parent drugs, 
there are about 40,000 different enzymes in human cells, each controlling a different chemical 
reaction. They increase the rate of reactions by a factor of 10
10
 to 10
18
 fold than the non-
enzymatic ones; among the most important enzymes involved in the bioconversion of prodrugs 
are those for amides, such as, trypsin, chymotrypsin, elastase,carboxy-peptidase, and amino-
peptidase and for esters, such as paraoxnase, carboxyl-esterase, acetylcholine-esterase and 
choline-esterase. Most of these enzymes are hydrolytic enzymes, however, non-hydrolytic ones, 
including all cytochrome P450 enzymes, are also capable of catalyzing the bioconversion of ester 
and amide-based prodrugs. The significant rate of acceleration obtained by enzymes is brought 
about by the binding of the substrate within the confines of the enzyme pocket called the active 
site. The binding energy of the resulting enzyme-substrate complex is the main driving force and 
the major contributor to catalysis. It is believed that in all enzymatic reactions, binding energy is 
used to overcome prominent physical and thermodynamic factors that create barriers for the 
reaction (ΔG) [20]. 
Enzyme catalysis maybe the most unpredictable approach, because there are many intrinsic and 
extrinsic factors can affect the bioconversion mechanism. For example there are genetic 
polymorphism of many enzymes can affect the bioconversion of the prodrug mechanism, drug 
interactions or age related physiological change can induce adverse clinical pharmacodynamic 
and pharmacokinetic effects, also there are a wide variation in expression and function of most of 
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enzymes activating the conversion of prodrugs, which could lead to serious challenges in the 
preclinical optimization phase [21]. 
Generally, enzymatic catalysis is required for most of prodrugs that are in clinical use in order to 
be converted into the parent drug. This is mainly for those prodrugs designed to furnish the 
parent drug in the blood stream following gastro-intestinal absorption. These prodrugs are 
mainly ester derivatives of drugs containing carboxyl or hydroxyl groups, which are converted 
into the parent drug by esterase-catalyzed hydrolysis, also non-enzymatic pathways for some 
prodrugs that can regenerate the parent drug, have emerged as an alternative approach by which 
prodrug activation is not influenced by inter- and intra-individual variability that affects the 
enzymatic activity [20]. 
 
2.1.1 Intramolecular vs.  Intermolecular reactions 
 
In some reactions, two pathways present themselves: one via intramolecular reaction and the 
other via intermolecular reaction. 
 Intramolecular forces: is any force that holds the atoms together making up a molecule or 
compound, they contain all types of chemical bond and are stronger than intermolecular 
forces[22]. The nature of the reaction (intermolecular or Intramolecular) is mainly 
dependent on the distance between the two reacting centers. Ab initio calculations done 
by Karaman and Menger demonstrated that when the distance between the two reacting 
centers is about 2.4Å, the reaction is intramolecular, whereas when the distance is 3Å and 
more, the reaction prefers the intermolecular process [23]. 
 Intermolecular forces: The forces holding molecules together and play important roles in 
determining the properties of substances [24]. 
 
In general, intermolecular forces can be divided into several categories: 
1. Strong ionic attraction, the more ionic, the higher the lattice energy.  
2. Intermediate dipole-dipole forces; substances whose molecules have dipole moment, 
have higher melting point or boiling point than those of similar molecular mass, but their 
molecules have no dipole moment.  
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3. Hydrogen bonding; certain substances such as H2O, HF, NH3 form hydrogen bonds, and 
the formation of which affects properties of substance. Other compounds containing OH 
and NH2 groups also form hydrogen bonds. Molecules of many organic compounds such 
as alcohols, acids, amines, and amino acids contain these groups, and thus hydrogen 
bonding plays an important role in biological science.  
4. Metallic bonding; forces between atoms in metallic solids belong to another category. 
Valence electrons in metals are rampant. They are not restricted to certain atoms or 
bonds. Rather they run freely in the entire solid, providing good conductivity for heat 
and electric energy. 
5. Weak London dispersion forces or van der Waal's force. These forces always operate in 
any substance.  
6. Covalent bonding; is intramolecular force rather than intermolecular force. Covalent 
bonding holds atoms tighter than ionic attraction.  
2.3 Prodrugs 
The most important chemical tool among the past few decades is known as prodrug, a modified 
physicochemical, pharmacokinetic and pharmacodynamic characteristics of a drug molecule. 
Many therapeutic drugs have undesirable properties in clinical drug application; among the 
various approaches to minimize the undesirable drug properties is the chemical approach using 
prodrug. 
Historically, the term prodrug was first introduced in 1958 by Albert [25]. Prodrugs are 
pharmacologically inactive chemical derivatives of a drug molecule that converted to its active 
form by enzymatic and/or chemical transformation within the body [26], and can be used to 
temporarily alter the physicochemical properties of a drug in order to increase its usefulness, by 
overcoming pharmaceutical, pharmacokinetic, or pharmacological barriers, such as poor 
solubility, low absorption, toxicity, lack of site specificity, insufficient chemical stability, and 
unacceptable odor/taste. Ideally, the prodrug should be converted to the parent drug and non-
toxic moiety as soon as its goal is achieved, followed by rapid elimination of the released linker 
moiety [28]. The use of the term usually implies a covalent link between a drug and a chemical 
moiety.  Prodrugs can be classified according to two major criteria: 
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 Chemical classes (carrier-linked prodrugs, bioprecursors, site-specific chemical delivery 
systems, etc.). 
 Mechanism of activation (enzymatic versus nonenzymatic, activation by oxidation, 
reduction or hydrolysis, catabolic versus anabolic reaction). 
2.3.1 Prodrug activation 
Prodrugs that are designed to be activated by natural enzymes such as esterases and amidases 
may be susceptible to premature hydrolysis during the absorption phase in enterocytes of 
gastrointestinal tract, this might produce more polar and less permeable prodrug which lead to  
decrease in the bioavailability [29], while if the prodrug is activated by cytochrome P450 
enzymes which are responsible for 75% of the enzymatic metabolism of prodrugs, a genetic 
polymorphisms might persist, which  lead to variability in prodrug activation and thus affect the 
efficacy and safety of designed prodrugs [30]. Thus, it might be difficult to predict the 
bioconversion rate of the enzymatic hydrolysis of the prodrug and hence a difficulty in predicting 
their pharmacological or toxicological effects. Moreover, the rate of hydrolysis is not always 
predictable [31-35]. 
To overcome these problems the novel prodrug approach for drugs that contain hydroxyl, amine, 
or phenol groups can be designed based on intramolecular processes (enzyme models). The 
design of prodrugs is based on computational calculations using different molecular orbital and 
molecular mechanics methods, and correlations between experimental and calculated rate values 
for some intramolecular processes. The impressive efficiency of enzyme catalysis has 
encouraged many organic chemists' and biochemists to explore enzyme mechanisms by 
investigating particular intramolecular processes such as enzyme models, which proceed faster 
than their intermolecular counterparts. This research brings about the important question of 
whether enzyme models will replace natural enzymes in the conversion of prodrugs to their 
parent drugs. 
There are two major prodrug design approaches that are considered as widely used among all 
other approaches to minimize or eliminate the undesirable drug properties. 
 The first approach is the chemical design approach by which the drug is linked to inactive 
organic moiety, which upon exposure to physiological environment releases the parent 
16 
 
drug and a non-toxic linker, which should be eliminated without affecting the clinical 
profile. 
 The second approach is the targeted drug design approach by which prodrugs can be 
designed to target specific enzymes or carriers by considering enzyme-substrate 
specificity or carrier-substrate specificity in order to overcome various undesirable drug 
properties. This type of "targeted-prodrug" design requires considerable knowledge of 
particular enzymes or carriers, including their molecular and functional characteristics 
[36-37]. 
In the past five decades, proposals have been made from attempts to interpret changes in 
reactivity versus structural variations in intramolecular systems.S cholarly studies have been 
done by, such as Bender, Jencks, Bruice,Menger, Kirby and Walesh have extensively studied a 
variety of intramolecular systems (enzyme models) for understanding how enzymes catalyze 
biochemical reactions. The similarity between intramolecularity and enzymes has excited a 
number of chemists and biochemists to design chemical models based on intramolecular 
reactions consisting of two reactive centers in order to gain additional information about the 
mode and the mechanism by which enzymes exert their high catalytic activities. Over the past 50 
years, suggestions have been made to interpret changes in reactivity versus structural variations 
in intramolecular systems [39]. 
Among the proposals and hypothesis advocated by the above mentioned scientists and others to 
explain enzyme catalysis are: 
 Koshland ‗‗orbital steering‘‘ which suggests a rapid intramolecularity arises from a 
severe angular dependence of organic reactions, such as in the lactonization of rigid 
hydroxy acids [40]. 
 ‗‗Proximity orientation‘‘ in intramolecular processes (near attack conformation) as 
proposed by Bruice and demonstrated in the lactonization of di-carboxylic acids 
semi-esters [41-43]. 
 ‗‗Stereopopulation control‘‘ based on the concept of freezing a molecule into a 
productive rotamer as advocated by Cohen [44-46]. 
 Manger‘s ‗‗spatiotemporal hypothesis‘‘ which postulates that the rate of reaction 
between two reactive centers is proportional to the time that the two centers reside 
within a critical distance [47-49]. 
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 Kirby‘s proton transfer models on the acid-catalyzed hydrolysis of acetals and N-
alkylmaleamic acids which demonstrated the importance of hydrogen bonding 
formation in the products and transition states leading to them [50]. 
 
Recently Karaman  s group has been researching the mechanistic pathways of some 
intramolecular processes that mentioned above which used as enzyme models. 
Utilizing DFT and ab initio molecular orbital calculation methods, Karaman  s group 
studied the following intramolecular processes (enzyme models): 
 
(a) Acid-catalyzed lactonization of hydroxy-acidsand proton transfer between two oxygens 
in rigid systems as investigated by Menger and Cohen, (b)SN2-based-cyclization 
reactions of di-carboxylic semi-esters to yield anhydrides as studied by 
Bruice,(c)intramolecular SN2-based ring-closing reactions as researched by Brown‘s and 
Mandolini‘s groups, (d) proton transfer between two oxygen‘s in Kirby‘s acetals and 
proton transfer between nitrogen and oxygen in Kirby‘s N-alkylmaleamic acids[2,50]. 
 
The conclusions raised up from these studies are: 
 
 The nature of the reaction being intermolecular or intramolecular is determined on the 
distance between the two reactive centers. The distance between the two reacting centers 
is the main factor in determining whether the reaction type is intermolecular or 
intramolecular. When the distance exceeded 3 Å, an intermolecular engagement was 
preferred because of the engagement with a water molecule (solvent). When the distance 
between the electrophile and nucleophile was <3 Å, an intramolecular reaction was 
dominant [50,51]. 
 The driving forces for enhancements in rate for intramolecular processes are both entropy 
and enthalpy effects. In the cases by which enthalpy effects were predominant such as 
ring closing and proton transfer reactions proximity or/and steric effects were the driving 
force for the rate accelerations [50]. 
 In SN2-based ring-closing reactions leading to three-, four- and five-membered rings the 
gem-dialkyl effect is more dominant in processes involving the formation of an 
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unstrained five-membered ring, and the need for directional flexibility decreases as the 
size of the ring being formed increases [50]. 
 Accelerations in the rate for intramolecular reactions are a result of both entropy and 
enthalpy effects [51].  
 An efficient proton transfer between two oxygens and between nitrogen and oxygen in 
Kirby‘s acetal systems were affordable when a strong hydrogen bonding was developed 
in the products and the corresponding transition states leading to them [50].  
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Chapter Three 
Computational (Design) section 
3.1 Computational Design 
The cost of developing a new drug can run into several billion dollars. The traditional process 
will usually take 10 or more years and result in the synthesis, purification and biological 
evaluation of ten thousand or more new compounds in order to produce a single potential drug 
candidate. By using computational design, it is possible for the user to create a set of new viable 
drugs. The output data raised from the calculation programs allows the user to explore each 
potential candidate and chose the best for production and further testing. By evaluating a large 
number of the most promising models and selecting, only the most promising cases it is possible 
to minimize production and testing costs [52]. 
Molecular modeling software allows the user to select atoms from the periodic table and to place 
them in a three dimensional workspace, the following programs were exploited in the design 
calculations: 
3.1.1 Arguslab. 
3.1.2 Gaussian2009. 
3.1.3 Molden. 
 
3.1.1 Arguslab: 
 
Arguslab, a free docking software program, is a molecular modeling, graphics, and drug design 
program that offers quite good on-screen molecule-building facilities, with a moderate library of 
useful molecules. This program can do geometry optimizations using the UFF force field. The 
resulting energies are clearly distinguishable from those obtained using some of the more 
conventional force fields, and wherever possible one needs to re-optimize at a higher level.  For 
this, Arguslab offers geometry optimization using the MNDO, AM1 or PM3 semi-empirical 
methods, as well as single point calculations. Version 3.1 of Arguslab has good facilities for 
calculating electron density or orbital surfaces at the semi-empirical levels, and displaying 
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them. There are also single point semi-empirical calculations using Extended Huckel (for a 
bigger element coverage) or ZINDO (for excited states for UV/visible absorption prediction) 
[52].  
Argus lab writes its own format of molecule file, like .xml, but it can also write xyz files for 
input to other programs, e.g. Molden.  It creates (and leaves behind) a lot of temporary files, 
which need to be managed. To start work using Arguslab, we press the 'New' button (top left) to 
get a new molecule screen, or press the 'Open' button to read in a molecule which have saved 
previously in the your Argus directory.  
In Arguslab, we need to save our molecule with whatever name we want before doing geometry 
optimizations well as afterwards. If we forget to change the file name before modifying a 
molecule, files will be auto-saved with the name used previously, possibly damaging data which 
we wanted to keep. It is best not to maximize the molecule window, because then its title bar will 
display the name by which we are currently saving the files. Just drag its bottom right corner so 
that it fills most of the Arguslab worktop. To stop using Argus lab, click File Exit, if we have 
molecule windows open, this will just close one of these.  We need to do it repeatedly to close all 
the windows (if we have several open) and then stop the program. 
 
3.1.2 Gaussian 2009 
 
Gaussian has implemented almost all the quantum mechanical methods, which include Hartree-
Fock and post Hartree-Fock method and DFT method. The current version Gaussian 09 is the 
latest version in the Gaussian series of computer for chemistry designed to model a broad range 
of molecular systems under a variety of conditions, performing its computations starting from the 
basic laws of quantum mechanics. 
The Gaussian program has been continuously developed by many researchers and today it is a 
software product that is used by thousands of chemists. It can be used to calculate the: 
 
 Electronic properties, charges, molecular energy, IR, Raman, UV, NMR and other 
spectroscopic properties of small to media molecules. 
 Comprehensive investigation of molecules and their reactions. 
 Predicting optical spectra including hyperfine spectra. 
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 Investigate thermo chemistry and excited state processes. 
 Gaussian_09 allows solvent effects to be taken into account when optimizing structures 
and predicting most molecular properties.  
 Prediction of the vibration frequencies and numerous molecular properties for systems in 
the gas phase and in solution. 
Traditionally, proteins and other large biological molecules have been out of reach of electronic 
structure methods. Theoretical study of molecules, their properties, and how they act together in 
chemical reactions can be done by the use Gaussian program. Experimental chemists can use it 
to study molecules and reactions of definite or potential interest, including both stable species 
and those compounds which are difficult or impossible to observe experimentally (short-lived 
intermediates, transition structures and so on) [53]. 
 
►Creating the first input file: input file scan be created in two ways: 
•By hand: using local editor (VI, emacs and nedit). 
• Using Molden. 
►Viewing output files from files run in Gaussian 09. Further, input files for use in Gaussian 09 
can be generated using Molden program. 
►Dissecting the output file:the Z-matrix represents how the software knows the molecular 
geometry (structure).  
 
3.1.3 Molden 
 
Molden is a computational program package made for displaying molecular densities from the 
ab-initio packages, Games-US, Games-UK and Gaussian, as well as Mopac/Ampac. 
Molden reads all the required information from the GAMESS GAUSSIAN output file. Molden is 
capable of displaying Molecular Orbital, the electron density and the Molecular minus Atomic 
density. 
The benefit of using this programs format is simple. Molden can interpret and convert 
information from all these programs into its own format, thereby providing a standardizing tool. 
The Molden program has a powerful Z-matrix editor which gives full control over the geometry 
23 
 
and allows you to build molecules from scratch, thereby allowing users to create the molecule of 
their choice and being able to save the geometry in the Molden format [54]. 
Molden format: 
 
 Incorporates numerous data stores in a text file. 
 Molden has a powerful Z-matrix editor which gives full control over the geometry and 
allows building molecules from scratch, including polypeptides. 
 Supports contour plots, 3-d grid plots with hidden lines and a combination of both. It can 
write a variety of graphics instructions; postscript, X-Windows, VRML, povray, 
OpenGL, tekronix4014 and hpgl, hp2392, also can animate reaction paths and molecular 
vibrations.  
 Molden can optimize geometries with the combined Amber (protein) and GAFF (small 
molecules) force fields.  
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3.2 Calculation methods 
3.2.1 Amoxicillin prodrugs 
The Becke three-parameter, hybrid functional combined with the Lee, Yang, and Parr correlation 
functional, denoted B3LYP, were employed in the calculations using density functional theory 
(DFT).Calculations were carried out based on the restricted Hartree-Fock method [54]. All 
calculated molecule have a starting geometry that were calculated using Arguslab program, and 
were initially optimized at the HF/6-31G level of theory, followed by optimization at the 
B3LYP/6-31G(d,p) also,  the calculations were carried out using the quantum chemical package 
Gaussian-2009 [55]. Total geometry optimizations included all internal rotations. Second 
derivatives were estimated for all 3N-6 geometrical parameters during optimization. Energy 
minimization (also called energy optimization, geometry minimization, or geometry 
optimization) is the process of finding an arrangement in space of a collection of atoms, 
according to some computational model of chemical bonding, the net inter-atomic force on each 
atom is acceptably close to zero, which refer to stable compound or a reactive intermediate 
exhibit the minimum energy with no negative vibrational force constant called energy minimum. 
 A transition state correspond to saddle points on the potential energy surface which has only one 
negative vibrational force constant [54]. Transition states were located first by the normal 
reaction coordinate method [56], where the enthalpy changes was monitored by changing the 
interatomic distance between two specific atoms, The vibrational frequencies are related to 
second derivatives; a minimum will have only positive frequencies while transition state should 
have one negative frequency. The vibrational analysis must be performed at the optimized 
geometry. Gaussian saves the optimized geometry into a checkpoint file, and the geometry can 
be recalled from this file before performing the vibrational analysis. The geometry at the highest 
point on the energy profile was re-optimized by using the energy gradient method at the 
B3LYP/6-31G(d, p) level of theory [54]. The activation energy values for the proton transfer 
processes (transfer of H7 from O6 into O1, Chart 1) were calculated from the difference in 
energies of the global minimum structures (GM) and the derived transition states.  
Verification of the desired reactants and products was accomplished using the ―intrinsic 
coordinate method‖ [56]. The transition state structures were verified by their only one negative 
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frequency. The activation energies obtained from the DFT at B3LYP/6-31G (d,p) level of theory 
for all molecules were calculated with and without the inclusion of solvent (water). The 
calculations with the incorporation of a solvent were performed using the integral equation 
formalism model of the Polarizable Continuum Model (PCM) [59-62].  
In this model, the cavity is created via a series of overlapping spheres. The search for the global 
minimum structure in each of the systems studied was accomplished by 36 rotations of the 
carboxyl group about the bond C4-C6 in increments of 10° (i.e. variation of the dihedral angle 
O5C4C6C7, see Chart 1) and calculation of the energies of the resulting conformers. 
 
Chart 1: Schematic representation of the reactants in the proton transfers of amoxicillin.  GM is 
the global minimum structure, rGM is the O—H distance in the GM. α, is the angle of attack 
(hydrogen bonding) O1-H7-O6 in the GM. 
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Chapter Four 
Results and Discussion 
 
4.1 Bitterless amoxicillin prodrugs based on Kirby’s maleamic acids enzyme model 
 
The Mechanistic study of the acid-catalyzed hydrolysis of maleamic acids1-7 (Fig.2) used for the 
design of amoxicillin prodrugs was kinetically investigated by Kirby. The study demonstrated 
that the amide bond cleavage is due to intramolecular nucleophilic catalysis by the adjacent 
carboxylic acid group and the rate-limiting step is the tetrahedral intermediate breakdown.  
 In order to utilize Kirby‘s enzyme model for the design of amoxicillin prodrugs, a mechanistic 
study using DFT calculation methods on an intramolecular acid catalyzed hydrolysis of 
maleamic (4-amino-4-oxo-2-butenoic) acids (Kirby‘s N-alkyl maleamic acids) 1-7 was 
conducted. 
 The calculations confirmed that the reaction involves three steps: 
(1) Proton transfer from the carboxylic group to the adjacent amide carbonyl oxygen. 
 (2) Nucleophilic attack of the carboxylate anion onto the protonated carbonyl carbon. 
 (3) Dissociation of the tetrahedral intermediate to provide products. 
The calculations indicated that the rate-limiting step is dependent on the reaction medium. 
When the calculations were run in the gas phase the rate-limiting step was the tetrahedral 
intermediate formation. Whereas when the calculations were conducted in the presence of a 
cluster of water, the dissociation of the tetrahedral intermediate was the rate-limiting step. 
In addition, when the leaving group (methylamine) in 1-7 was replaced with a group having a 
low pKa value the rate-limiting step of the hydrolysis in water was the formation of the 
tetrahedral intermediate and the rate of hydrolysis was found to be linearly correlated with the 
strain energy of the tetrahedral intermediate or the product. Systems having strained tetrahedral 
intermediates or products experience low rates and vice versa. 
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Figure 2: Acid catalyzed hydrolysis of N-alkylmaleamic acid 1-7. 
 
Furthermore, Karaman‘s calculations revealed a correlation between the acid-catalyzed 
hydrolysis efficiency and the following parameters: 
1. The distance between the hydroxyl oxygen of the carboxylic group and the amide carbonyl 
carbon. 
2. The attack angle.  
3.The difference between the strain energies of intermediate, product, intermediate, and reactant.  
The aim of this work was to design various amoxicillin prodrugs that lack the bitterness of their 
parent drug and have the capability to chemically undergo hydrolysis in the intestine to give the 
active drug. Scheme 1 illustrates possible approaches for the design of amoxicillin prodrugs. 
 In this section, we report DFT at B3LYP 6-31G (d,p) level calculations of ground state and 
transition state structures, vibrational frequencies, and reaction trajectories for intramolecular 
proton transfer in amoxicillin prodrugs ProD1-ProD5. 
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Scheme 1: Proposed amoxicillin prodrugs. 
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As shown in (Scheme.1) the combination of both, the hydrophilic and lipophilic groups provides 
a prodrug entity with a potential to be with a high permeability (a modified HLB). The 
amoxicillin prodrugs ProD1-5 have a carboxylic acid group (hydrophilic moiety) and a 
lipophilic moiety (the rest of the molecule), it should be noted that the HLB value will be 
determined upon the physiologic environment by which the prodrug is dissolved. 
In the stomach where the pH is in the range 1-2, it is expected that amoxicillin ProD1-5 will be 
in a free carboxylic acid form (a relatively high hydrophobicity) whereas in the blood stream 
circulation where the pH is 7.4 a carboxylate anion (a relatively low hydrophobicity) is expected 
to be predominant form. At pH 5, the hydrolysis of ProD1-5 was too slow. This is because the 
pKa of amoxicillin prodrugs is in the range of 3-4, it is expected that at pH 5, the anionic form of 
the prodrug will be dominant and the percentage of the free acidic form that undergoes an acid-
catalyzed hydrolysis will be relatively low.  
Our strategy was to prepare amoxicillin prodrugs as sodium or potassium carboxylates due to 
their high stability in neutral aqueous medium. It should be indicated that compounds 1-7 
undergo a relatively fast hydrolysis in acidic aqueous medium whereas they are quite stable at 
neutral pH. For example, for prodrugs intended to be given as solutions or syrups to children or 
pediatrics (for masking the bitterness of the parent drug) the prodrug will reach the stomach and 
it will primarily exist in the carboxylic acid form whereas in the blood circulation (in the cases of 
IV injection dosage form) the carboxylate anion form will be predominant. It is planned that the 
prodrugs will be obtained as sodium or potassium salts and will be given to adults in the form of 
enteric coated tablets in order to assure release of the parent drug in the intestine (pH 6-8) and 
not in the stomach (pH 1). This is because the linkers (Kirby‘s enzyme model) undergo fast 
hydrolysis at low pH such as the stomach. On the other hand, the prodrugs when dissolved in the 
intestine they can exist in both the carboxylate and free carboxylic acid forms (the ratio between 
the two forms will be determined on the pka value of the prodrug).  
Karaman found that the proton transfer is the rate-limiting step in the hydrolysis. Also the 
driving force for the proton transfer efficiency is the proximity of the two reactive centers (rGM) 
and the attack angle (α); and the rate of the reaction is linearly correlated with rGM
 2
 and sin 
(180°- α) short rGM values and with α values close to 180° (forming a linear H-bond) are more 
reactive due to the development of a strong hydrogen bonds in their transition state and product 
structures [50,55,63-96]. 
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4.1.1 General Consideration:  
The carboxylic acid moiety could be engaged in intermolecular or intramolecular hydrogen 
bonding. Therefore, the free energy of the reactant is strongly dependent on its conformation. We 
were concerned with the identification of the most stable conformation (Global Minimum, GM) 
for each prodrug in this study. The search for the global minimum structures for all prodrugs 
studied was accomplished by 360
0
 rotations of the carboxyl group about the bond C3-C4 in 
increments of 10° (i.e. variation of the dihedral angle O5C4C3C2, see Chart 1) and calculation of 
the energies of the resulting conformers. 
 Two different types of conformations were considered in the DFT calculations of the starting 
geometries in amoxicillin ProD1-5: 
 One in which the carboxylic hydroxyl proton is syn to the alkoxy group in the β position 
of the carboxylic acid moiety (dihedral angle O5C4C3C2 = 0, Chart 1). 
 Another in which it is anti (dihedral angle O5C4C3C2 = 180, Chart 1).  
The global minimum search for amoxicillin ProD1-5 revealed that ProD4 and ProD5 exist in 
the syn orientation and ProD1, ProD2 and ProD3 exist in the anti-orientation.  
4.1.2 Optimized geometries of the entities involved in the proton transfers of amoxicillin 
ProD1-5.  
Using the quantum chemical package Gaussian-98 [53], I have calculated the DFT B3LYP/6-
31G (d,p) kinetic and thermodynamic parameters for the proposed amoxicillin prodrugs. 
(Figure.3a) and (Table.1) illustrates the DFT calculated properties for the global minimum 
structures of amoxicillin ProD1-ProD5, (Table.2) illustrates the DFT (B3LYP/6-31G (d,p) 
calculated kinetic and thermodynamic properties for the proton transfers in amoxicillin ProD1-
ProD5. 
The DFT calculated properties for the global minimum structures of amoxicillin ProD1-5 
(ProD1GM- ProD5GM) indicates that amoxicillin ProD1GM, ProD2GM and ProD3GM exist 
in conformation by which the carboxylic hydroxyl group forms hydrogen bond with a molecule 
of water rather than intramolecularly. The preference of the carboxyl group in amoxicillin 
ProD1GM, ProD2GM and ProD3GM to be engaged intermolecularly with the solvent and not 
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intramolecularly is due to the fact that the latter is energetically expensive due to a high-energy 
barrier for the rotation of the carboxyl group around the C3-C4 bond.  
On the other hand, the optimized geometries of amoxicillin ProD3GM and ProD4GM exist in 
conformation by which the carboxylic hydroxyl proton is engaged intramolecularly via hydrogen 
bonding with the neighboring alkoxy oxygen. Examination of the optimized global minimum 
structures in (Fig.3a) indicates that the DFT calculated hydrogen bonding length (rGM) in the 
reactants engaged intermolecularly with a water molecule for ProD1GM, ProD2GM and 
ProD3GM was in the range of 4.08 Å-5.97 Å and the attack angle α (the hydrogen bond angle, 
O1H7O6) in the range of 27°-30°. On the other hand, the rGM and α value for amoxicillin 
ProD3GM and ProD4GM were 2.21Å-2.30Å and 142.09°-156.41°, respectively. It should be 
indicated that the hydrogen bonding length, rGM (O1-H7), varies according to the structural 
features of the reactant geometry. The optimized DFT calculated transition state geometries for 
amoxicillin ProD1-5 are illustrated in (Fig.3b).  
 
 
 
Figure 3: DFT optimized structures for the global minimum (GM) structures in the intramolecular proton 
transfer reaction of amoxicillin ProD1- 5. 
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Figure 4: DFT optimized structures for the transition state (TS) structures in the intramolecular proton 
transfer reaction of amoxicillin ProD1-5. 
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Table 1: DFT (B3LYP) calculated properties for the proton transfer reactions of in amoxicillin 
ProD1-5. 
Compound B3LYP, Enthalpy, H 
(gas phase) in Hartree 
B3LYP (gas phase) 
Entropy, S, 
Cal/Mol-Kelvin 
B3LYP 
Frequency 
Cm
-1
 
Amoxicillin ProD1GM -2018.925608 221.224 ------- 
Amoxicillin ProD1TS -2018.866062 208.552 44.561i 
Amoxicillin ProD2GM -1940.29406 212.567 ------- 
Amoxicillin ProD2TS -1940.229544 196.496 59.346i 
Amoxicillin ProD3GM -2135.662449 232.801 ------- 
Amoxicillin ProD3TS -2135.609573 214.596 30.094i 
Amoxicillin ProD4GM -2017.664638 219.198 ------- 
Amoxicillin ProD4TS -2017.649627 210.773 101.143i 
Amoxicillin ProD5GM -1939.024531 203.732 ------- 
Amoxicillin ProD5TS -1938.996431 194.085 132.041i 
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Table 2: DFT (B3LYP/6-31G (d,p) calculated kinetic and thermodynamic properties for the 
proton transfers in amoxicillin ProD1-5. 
System ∆ES ∆H‡ 
(GP) 
TΔS‡ 
(GP) 
∆G‡ 
(GP) 
∆H‡ 
(H2O) 
∆G‡ 
(H2O) 
ProD1 15.7 37.36 -3.76 41.13 42.75 46.51 
ProD2 14.0 40.48 -4.77 45.26 47.15 51.92 
ProD3 14.5 33.18 -5.41 38.58 40.73 46.13 
ProD4 2.3 9.42 -2.50 11.92 16.40 18.90 
ProD5 3.1 17.63 -2.86 20.49 24.80 27.66 
1 0.3 27.31 28.08 32.29 33.06 0 
2 5.3 13.93 16.42 17.56 20.05 4.37 
3 6.9 24.41 24.90 27.93 28.42 1.49 
4 15.6 34.42 36.77 35.76 38.11 -4.3 
5 10.1 13.25 17.41 18.96 23.12 2.73 
6 12.5 23.83 23.92 27.19 27.28 1.51 
7 12.4 24.86 25.03 27.38 27.55 1.64 
 
∆H‡ is the activation enthalpy energy (kcal/mol). TΔS‡ is the activation entropy energy in 
kcal/mol. ∆G‡ is the activation free energy (kcal/mol).GP and H2O calculated in the gas phase 
and water, respectively. 
  
4.1.3 The role of the distance O1-H7 (rGM) and the angle O1H7O6 (α) on the rate of the 
proton transfer in processes amoxicillin ProD1-5 
Careful inspection of the optimized structures for the global minimum (GM) structures in the 
intramolecular proton transfer reaction of amoxicillin ProD1-5 in (Fig.3a) indicates that the 
distance between the two reactive centers rGM (O1-H7) varies according to the conformation of 
the global minimum structure (GM).  
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Short rGM distance values were achieved when the values of the attack angle (α) in the GM 
conformations were high and close to 180°, whereas small values of α resulted in longer rGM 
distances. In fact when the rGM values were plotted against the corresponding α values linear 
correlation was obtained with r = 0.996 (Fig.4). In addition, examination of the activation energy 
values (∆G‡) listed in (Table.2) reveals that the energy needed to execute proton transfer in 
amoxicillin ProD1-5 is largely affected by both the distance between the two reactive centers 
rGM (O1-H7), and the attack angle α (O1H7O6).  
When rGM and α values were examined for correlation with the calculated DFT enthalpy energies 
(∆H‡) a linear correlation was found between ∆H‡ and rGM
2
 x sin (180-α) with a correlation 
coefficient of r = 0.983(Fig.5), and the activation free energies (∆G‡) with rGM
2
 x sin (180-α) 
gave an r = 0.987(Fig.6). 
Systems with low rGM and high α values in their global minimum structures, such as ProD4 and 
ProD5 exhibit much higher rates (lower ∆G‡) than these with high rGM and low α values, such as 
ProD1, ProD2 and ProD3. In the case ProD1, ProD2 and ProD3 the interatomic distance 
between the nucleophile (OH) and electrophile (C=O) is too high to make the nucleophile attack 
accessible. 
According to structural feature of 2,3-dimethylmaleatmoiety it contains two methyl groups on 
the C-C double bond (strained system) which results in a decrease of the distance between the 
two reactive centers (hydroxyl oxygen of the carboxylic group and the amide carbonyl carbon). 
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Figure 5: Plot of the DFT calculated rGM (Å) vs. angle α (°) in amoxicillin ProD1-5, where (rGM) 
and (α) are the distance between the two reactive centers and the attack (hydrogen bond) angle in 
the GM structure, respectively. 
 
 
Figure 6: Plot of the DFT calculated ∆H‡ vs. rGM
 2
 x sin (180-α) in amoxicillin ProD1-5 
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Figure 7: Plot of the DFT calculated ∆G‡vs. rGM
 2
 x sin (180-α) in amoxicillin ProD1-5. 
 
4.1.4 The role of the strain energy on the rate of the proton transfer in amoxicillin ProD1-
5 : 
To investigate the role of the steric effects we computed using Allinger‘s MM2 method. The 
strain energies for the reactants, intermediates in 1–7 and amoxicillin ProD1-ProD5. The rate of 
hydrolysis for 1-7 was found to be linearly correlated with the strain energy of the tetrahedral 
intermediate. The correlation results illustrated in (Fig.7) demonstrate a good correlation 
between the experimental log krel and the MM2 calculated intermediate strain energy values 
(Es) with a correlation coefficient (r) of 0.88. 
The DFT calculation results revealed that the rate of a proton transfer in processes of amoxicillin 
ProD1-ProD5 and 1-7 is governed by strain effect. The rate of hydrolysis was found to be 
linearly correlated with the strain energy difference between the intermediate and the reactant 
(Es INT-GM). Therefore ProD4 has lowest difference in strain energy so; it has the highest rate 
of proton transfer. 
In order to further support this conclusion, activation energy values for 1-7 as calculated in 
dielectric constant of 78.39 (water) (∆G‡ H2O, see Table 2) were examined for correlations with 
both log krel for system 1-7 and ΔEs for amoxicillin prodrugs (Fig.8) and (Fig.9) with a 
correlation coefficient of 0.93 and 0.92 respectively. 
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Figure 8:  Plot of the ES for intermediates of 1-7 N-alkylmaleamic acid vs. relative rate (log 
krel). 
 
 
Figure 9: Plot of the DFT calculated ∆G‡ vs. relative rate (log krel) in 1-7 N-alkylmaleamic acid. 
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Figure 10: Plot of the DFT calculated ∆G‡ vs. MM2 calculated difference in strain energies 
between intermediates and reactants ES (INT-GM)) in amoxicillin ProD1- ProD5. 
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Chapter Five 
Conclusions and future directions 
 
5.1 Conclusions and Future directions 
 
Amoxicillin as mentioned before suffer bitter taste sensation and low stability. Several attempts 
were made in order to enhance their aqueous solubility and bioavailability. Among several 
research approaches, the prodrug approach has been widely used for an improvement of drugs 
delivery to their site of action by physicochemical modulation that affect absorption or by 
targeting to specific enzymes or membrane transporters.  
The DFT calculation results revealed that the rate of a proton transfer in processes amoxicillin 
ProD1-ProD5 is largely dependent on the geometric variations of the reactant (GM), mainly the 
distance between the two reactive centers, rGM, and the angle of attack α.  It was found that 
reactants with short rGM and α values close to 180º strong intramolecular hydrogen bonding 
provide stable transition states that lead to acceleration in rate. Also the rate of hydrolysis was 
found to be linearly correlated with the strain energy difference between the intermediate and the 
reactant (Es INT-GM). 
In addition, the calculations indicated that the nature of the mechanism rely on the 
reaction solvent (medium). In aqueous medium the reaction rate-limiting step is the collapse 
of the tetrahedral intermediate whereas in the gas phase the tetrahedral intermediate 
formation is the rate-limiting step. 
According to the DFT calculations and the designed amoxicillin prodrugs, it is recommended to 
synthesize amoxicillin ProD4 and ProD5 using Kirby‘s synthetic procedure. In vitro kinetic 
studies at different pH values should be made in order to be utilized for the in vivo 
pharmacokinetic studies, which should be followed to determine the t1/2 values for the 
conversion of the amoxicillin ProD4 and ProD5 to its parent drug, amoxicillin. Bitter sensation 
studies should be conducted for amoxicillin prodrugs to determine if the designed prodrugs have 
or lack any bitter taste. 
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In the in vivo studies, the prodrug should be administered to animals by intravenous injection and 
oral administration, blood and urine samples should be collected at different times. The 
concentration of amoxicillin should be determined using a reliable bio-analytical method. 
Further, pharmacokinetic parameter values should be calculated including oral bioavailability, 
terminal elimination half-life and other pharmacokinetic parameters as deemed necessary. 
 
5.2 Future directions 
 
Future strategy to achieve more efficient amoxicillin  prodrugs capable of  eliminating 
amoxicillin bitterness, and releasing the parent drug in a programmable manner is (a) synthesis 
of amoxicillin prodrugs having around pH 6 (intestine pH) such as amoxicillin ProD4 and 
ProD5; (ii) in vitro kinetic studies of these prodrugs performed at pH 6.5 (intestine) and pH 7.4 
(blood circulation system); and (iii) in vivo pharmacokinetic studies should be done in order to 
determine the bioavailability and the duration of action of the tested prodrug. Furthermore, based 
on the in vivo pharmacokinetics characteristics of amoxicillin ProD4 and ProD5, new prodrugs 
may be design and synthesized. 
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ProD1GM 
C -2.117941 -1.102334 2.329747  
C -1.142765 -1.132309 1.330078  
C -1.538090 -0.915967 0.008759  
C -2.867830 -0.650729 -0.315647  
C -3.833581 -0.613255 0.689405  
C -3.451025 -0.850667 2.016207  
O -0.658651 -0.927723 -1.069879  
C 0.554163 -1.569335 -0.933688  
O 1.475704 -0.666483 -0.288333  
C 2.828919 -0.920310 -0.331505  
C 3.700631 0.153049 -0.034300  
C 5.081419 -0.095484 -0.045550  
C 5.587882 -1.355074 -0.353749  
C 4.712481 -2.398136 -0.648018  
C 3.333665 -2.187674 -0.634449  
C 3.254450 1.555722 0.290928  
O 1.951144 1.848050 0.215352  
C -5.277044 -0.286322 0.368055  
O -5.585936 -0.826658 -0.917483  
O 4.040769 2.427258 0.620215  
C -5.570025 1.231241 0.440120  
N -4.773280 2.034896 -0.473782  
C -5.329893 2.199535 -1.812460  
O 6.845393 2.753823 0.233223  
H 5.760856 0.723359 0.169327  
H 6.660479 -1.516914 -0.365829  
H 2.663607 -3.012349 -0.846051  
H 5.094702 -3.386177 -0.886785  
H 1.440085 1.055809 -0.042229  
H 0.924363 -1.791641 -1.938919  
H 0.468799 -2.482985 -0.331771  
H -3.141348 -0.488176 -1.349890  
H -0.102251 -1.293534 1.585972  
H -4.198664 -0.838136 2.804964  
H -1.826132 -1.275257 3.361282  
H -5.910902 -0.761872 1.135880  
H -5.360905 1.553488 1.466480  
H -6.660796 1.368403 0.284933  
H -6.503753 -0.597723 -1.116156  
H -4.601138 2.944972 -0.061900  
H -4.713725 2.906565 -2.375421  
H -6.372346 2.571480 -1.821023  
H -5.309942 1.243389 -2.339903  
H 5.874233 2.735534 0.304675  
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H 7.127864 2.859649 1.150481  
 
ProD 1TS 
 
C -2.617666 1.440983 0.296984  
O -1.571318 -0.598029 0.002354  
C -0.434249 -1.143428 0.847965  
O 0.312908 -0.093580 1.265102  
C 1.192628 0.477070 0.315412  
C 0.819620 1.672666 -0.291556  
C 1.710479 2.248042 -1.197834  
C 2.930414 1.630506 -1.478742  
C 3.292834 0.434631 -0.849631  
C 2.409008 -0.145301 0.066049  
C 4.644305 -0.190854 -1.122342  
O 4.497311 -1.611217 -1.055689  
N 5.455645 0.049445 1.248410  
C 5.946157 -1.230281 1.749731  
C 5.737851 0.319438 -0.154240  
C -3.829558 1.024110 0.138055  
O -4.863669 1.694585 0.143469  
C -3.947665 -0.487032 -0.067796  
C -2.811910 -1.298805 -0.110334  
C -2.843309 -2.674279 -0.280461  
C -4.097679 -3.278250 -0.409044  
C -5.261100 -2.505913 -0.379649  
C -5.183588 -1.120308 -0.209347  
O -3.992219 4.412701 0.615037  
H -1.837564 0.319031 0.199174  
H 6.705526 -0.112756 -0.481988  
H 5.818793 1.402737 -0.298039  
H 7.026721 -1.394665 1.578728  
H 5.760486 -1.292567 2.825967  
H 5.363396 -2.001977 -1.233272  
H 5.822274 0.802465 1.819436  
H 3.607281 2.083860 -2.198508  
H 2.677441 -1.063221 0.574170  
H 1.443305 3.174573 -1.696025  
H -6.067369 -0.491816 -0.176062  
H -6.228992 -2.985571 -0.485520  
H -4.157098 -4.353327 -0.545611  
H -1.933479 -3.263208 -0.324190  
H -0.897887 -1.633859 1.705014  
H -0.142669 2.121834 -0.067213  
H 4.958005 0.106655 -2.136986  
H 0.086706 -1.835359 0.181969  
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H 5.401714 -2.045611 1.267975  
H -4.309262 3.507740 0.434240  
H -3.055033 4.253305 0.782406  
 
 
ProD2GM 
 
C 1.438231 1.522745 1.445555  
C 0.408264 0.584462 1.328142  
C 0.625634 -0.562173 0.553960  
C 1.849700 -0.748698 -0.096668  
C 2.873343 0.192323 0.024637  
C 2.661884 1.338050 0.805211  
N -0.300601 -1.561353 0.357432  
C -1.435284 -1.620309 1.204548  
O -2.398796 -0.641938 0.940111  
C -3.105560 -0.788427 -0.310104  
C -3.653182 0.616177 -0.673787  
C -4.982078 0.880943 0.040154  
C -6.076048 -0.075394 -0.491547  
C -5.492790 -1.424953 -0.974248  
C -4.250599 -1.820099 -0.162888  
C -2.599924 1.667294 -0.375211  
O -1.510682 1.504709 -1.166032  
C 4.219550 -0.052227 -0.637904  
O 4.843302 1.165811 -1.044176  
O -2.684773 2.547038 0.451595  
C 5.194790 -0.772030 0.325187  
N 6.444417 -1.275278 -0.219504  
C 7.449390 -0.289915 -0.613966  
H -4.826937 0.736163 1.114079  
H -6.813165 -0.251927 0.299920  
H -4.512317 -1.869829 0.900871  
H -6.250638 -2.212567 -0.907379  
H -0.841831 2.134247 -0.847420  
H -1.141386 -1.477876 2.249817  
H -1.828675 -2.631980 1.053974  
H -3.807135 0.628058 -1.760724  
H -5.279780 1.925429 -0.083539  
H -6.620129 0.397844 -1.317067  
H -2.388428 -1.095570 -1.077907  
H -3.904099 -2.817757 -0.453524  
H -5.221588 -1.359588 -2.035909  
H 1.981958 -1.644223 -0.697474  
H -0.550059 0.767416 1.797480  
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H 3.453548 2.074585 0.890890  
H 1.269654 2.414062 2.043521  
H 4.066357 -0.711109 -1.510474  
H 4.648896 -1.616579 0.763392  
H 5.423853 -0.080145 1.145194  
H 4.225467 1.632319 -1.623326  
H 6.259681 -1.916680 -0.986047  
H 7.666455 0.356423 0.243443  
H 7.164640 0.361222 -1.451250  
H 8.375220 -0.815747 -0.871882  
 
ProD 2TS 
 
C 2.867289 2.131705 -0.317291  
O 2.219834 0.193506 -0.924681  
C 3.008421 -0.429133 0.232046  
C 3.259218 -1.900390 -0.084338  
C 4.344959 -2.430251 0.870048  
C 5.703460 -1.703573 0.657358  
C 5.531861 -0.365928 -0.090690  
C 4.293546 0.384697 0.404432  
C 4.111294 1.806227 -0.202731  
O 5.098625 2.463670 -0.500004  
C 1.059111 -0.554455 -1.423103  
O 0.199949 -0.974237 -0.421332  
C -0.823596 -0.106854 -0.018208  
C -2.102474 -0.657878 0.039364  
C -3.185035 0.124736 0.450518  
C -2.959414 1.460966 0.809422  
C -1.675110 1.997460 0.755336  
C -0.588008 1.220358 0.345270  
C -4.593747 -0.447596 0.459080  
O -5.381825 0.103159 1.512115  
C -5.323939 -0.139372 -0.872620  
N -6.593104 -0.795981 -1.123150  
C -7.741058 -0.383361 -0.318307  
H 2.040416 1.140198 -0.775654  
H 0.581973 0.143876 -2.121298  
H 1.441958 -1.435914 -1.932514  
H 2.338136 -0.317562 1.085677  
H 2.338457 -2.482411 0.015068  
H 3.613518 -1.999394 -1.117415  
H 3.998789 -2.296900 1.902513  
H 4.450191 -3.509972 0.725365  
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H 6.394405 -2.348264 0.102872  
H 6.168655 -1.521706 1.632725  
H 6.397405 0.286178 0.042265  
H 4.404562 0.542855 1.486736  
H -2.235837 -1.698165 -0.243137  
H -3.797009 2.062481 1.145860  
H -1.504537 3.030044 1.043788  
H 0.409158 1.648868 0.350289  
H -4.982581 -0.157613 2.352955  
H -4.528569 -1.544547 0.558535  
H -4.637300 -0.401908 -1.687035  
H -5.476326 0.946188 -0.922485  
H -6.483251 -1.805760 -1.096516  
H -8.642351 -0.854559 -0.724983  
H -7.866318 0.700748 -0.410897  
H -7.671560 -0.614210 0.752976  
H 5.451842 -0.537018 -1.171355  
 
ProD 3GM 
 
C 3.296172 -2.178864 -0.297354  
C 4.004272 -1.312677 0.783789  
C 4.027755 0.106299 0.271541  
C 2.832201 0.650990 -0.026323  
C 1.665973 -0.312430 0.198130  
C 1.908439 -1.584369 -0.654319  
N 3.076104 -1.312999 2.040543  
C 1.682033 -0.734800 1.686680  
O 0.366849 0.296208 -0.025216  
C -0.154236 0.347578 -1.346511  
O -0.772245 -0.844444 -1.754709  
C -2.024489 -1.152849 -1.261909  
C -2.612984 -0.517538 -0.165806  
C -3.900144 -0.893727 0.245566  
C -4.572967 -1.916982 -0.428472  
C -3.966520 -2.556709 -1.511926  
C -2.695146 -2.180333 -1.934121  
C -4.554504 -0.169673 1.415196  
C -5.361168 1.065688 0.977084  
N -4.594959 1.997953 0.164979  
C -5.311498 3.237929 -0.105290  
C 2.726263 2.096505 -0.390692  
O 3.660345 2.764812 -0.799056  
C 5.398210 -1.849085 1.113377  
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O 1.526018 2.677653 -0.213101  
O -3.604708 0.268422 2.380693  
O 6.415590 2.064675 -0.987069  
H 4.960569 0.656850 0.171332  
H 1.860939 -1.342517 -1.718034  
H 3.931166 -2.233957 -1.186513  
H 0.893364 2.001111 0.108583  
H -0.872174 1.173906 -1.341034  
H 0.633970 0.535941 -2.079706  
H 1.101997 -2.294175 -0.452838  
H 5.880957 -1.242466 1.886841  
H 6.043286 -1.835959 0.229005  
H 5.344816 -2.880131 1.479031  
H 3.192497 -3.201086 0.084347  
H 1.440758 0.136519 2.302633  
H 0.886079 -1.470301 1.840638  
H 2.988946 -2.341335 2.409394  
H 3.548403 -0.728832 2.836170  
H -2.093500 0.247657 0.396182  
H -5.563631 -2.221054 -0.101175  
H -4.487097 -3.356396 -2.030648  
H -2.209367 -2.661107 -2.776507  
H -5.277708 -0.859974 1.880491  
H -5.670126 1.583353 1.893055  
H -6.285963 0.709937 0.482299  
H -3.081681 -0.501165 2.642811  
H -4.351346 1.549557 -0.714231  
H -4.715200 3.866420 -0.773484  
H -5.452690 3.790670 0.830289  
H -6.309136 3.101646 -0.563291  
H 5.472942 2.313080 -0.955132  
H 6.836252 2.707803 -0.402793  
 
 
ProD 3TS 
C -2.858698 -2.576873 -1.350178  
C -2.135969 -1.433870 -1.001878  
C -2.617167 -0.532333 -0.055867  
C -3.865442 -0.765797 0.542019  
C -4.594328 -1.907178 0.198012  
C -4.089634 -2.807622 -0.743267  
N -0.914242 -1.290286 -1.659111  
C -0.305060 -0.061927 -1.704347  
O 0.415336 0.239112 -0.453469  
C 1.740683 -0.411051 -0.080957  
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C 2.815522 0.658818 -0.070380  
C 3.995464 0.169613 0.341115  
C 4.016723 -1.301985 0.699772  
C 3.518245 -2.087947 -0.551494  
C 2.147432 -1.538922 -1.046297  
C 1.559158 -0.988501 1.332685  
C 2.943920 -1.511152 1.814202  
C 2.539600 2.112007 -0.435823  
O 3.480578 2.908106 -0.484675  
C 5.393747 -1.789699 1.151215  
C -4.401868 0.237525 1.552972  
C -5.163242 1.404249 0.895149  
N -4.420715 2.042579 -0.181933  
C -4.958534 3.344755 -0.561535  
O 1.294793 2.378262 -0.648738  
O -3.362507 0.811419 2.337510  
O 6.245001 2.658714 -0.084710  
H 0.640657 1.187535 -0.472147  
H 5.275287 2.726565 -0.197439  
H 6.565564 2.459769 -0.971777  
H -4.391068 3.739156 -1.409492  
H -4.837183 4.045098 0.271554  
H -6.028520 3.336614 -0.839052  
H -5.327602 2.147070 1.683709  
H -6.160373 1.037474 0.586906  
H -5.126594 -0.282535 2.200718  
H -2.879541 0.088368 2.759981  
H -2.057150 0.341154 0.252828  
H -5.552892 -2.098874 0.672609  
H -4.656695 -3.696066 -1.003954  
H -2.447951 -3.259380 -2.086268  
H -1.004463 0.774218 -1.787735  
H 0.409744 -0.070761 -2.524918  
H 0.810652 -1.787647 1.302802  
H 1.178433 -0.201682 1.989087  
H 2.251181 -1.148614 -2.061877  
H 1.382871 -2.319802 -1.061451  
H 3.429346 -3.149791 -0.295327  
H 4.263372 -2.010153 -1.347912  
H 2.887510 -2.577291 2.062145  
H 4.880749 0.797036 0.418028  
H 5.732685 -1.237427 2.033446  
H 6.138933 -1.643667 0.362595  
H 5.373210 -2.855242 1.405086  
H -4.418531 1.430707 -0.993496  
H 3.258386 -0.985165 2.719699  
58 
 
 
ProD 4GM 
C    -1.880370    -1.209324     0.078365 
 H    -0.913044    -1.314117    -0.042036 
 O     0.788793    -1.221505    -0.294902 
 C     1.226641     0.078996    -0.221335 
 C     0.229510     1.060389    -0.041819 
 C    -1.210209     1.126186     0.078114 
 C    -2.279271     0.065939     0.092415 
 O    -3.454932     0.351844     0.132987 
 H    -4.615533    -1.278718    -0.050697 
 O    -5.133517    -2.093576    -0.144202 
 H    -4.514117    -2.768131     0.156603 
 N    -1.612326     2.365697     0.223332 
 O    -0.483165     3.176177     0.207210 
 C     0.616914     2.400368     0.048999 
 C     1.935254     2.847550    -0.026638 
 C     2.889713     1.857608    -0.197687 
 C     2.552706     0.490761    -0.289416 
 C     1.596001    -2.302410    -0.836163 
 O     1.997992    -3.190976     0.132486 
 C     3.071444    -2.757887     0.965575 
 H     3.960127    -2.513916     0.368872 
 H     2.788624    -1.890935     1.571113 
 H     3.305818    -3.592996     1.624699 
 H     2.427419    -1.863405    -1.398910 
 H     0.924796    -2.843832    -1.501679 
 H     3.349728    -0.230482    -0.404897 
 H     3.936770     2.132840    -0.258986 
 H     2.185062     3.897687     0.044780 
 
 
 ProD4TS 
C    -1.739320    -0.503634    -0.371521 
N    -0.936692     0.590886    -0.557836 
 O    -0.334437     1.338724    -0.388568 
 C    -0.953206     2.105419     0.817524 
 O    -1.793107     3.041296     0.355738 
 C    -1.183004     4.205127    -0.221571 
 C    -1.274527    -1.683629    -0.121428 
 O    -1.913512    -2.716785     0.043983 
 C     0.246518    -1.720502    -0.017062 
 N     0.942058    -2.816516     0.136484 
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 O     2.309129    -2.446133     0.190073 
 C     2.399606    -1.103760     0.067428 
 C     1.114414    -0.573227    -0.062841 
 C     0.977819     0.806245    -0.212569 
 C     2.088030     1.628942    -0.231617 
 C     3.368875     1.053453    -0.082441 
 C     3.553832    -0.317245     0.069264 
 H     4.538592    -0.755074     0.178094 
 H     4.234460     1.706966    -0.097007 
 H     1.979165     2.698352    -0.374430 
 H    -0.068703     2.470385     1.348696 
 H    -1.510430     1.332691     1.345667 
 H    -0.699603     3.953084    -1.169966 
 H    -1.989779     4.914633    -0.398997 
 H    -0.452035     4.641707     0.469596 
 H    -3.778163    -2.172196     0.018566 
 O    -4.698030    -1.850747     0.000041 
 H    -4.587137    -0.972517    -0.383875 
 
 
 
 ProD5GM 
 O     5.062547     0.513757    -0.001538 
N    4.277273    -0.077442    -0.002733 
 O     2.746450    -1.109107    -0.000949 
 C     1.817280    -0.285661     0.000952 
 O     1.918318     0.989328     0.002799 
 C     0.383205    -0.811877     0.000361 
 N     0.123827    -2.096166     0.000410 
 O    -1.295085    -2.229044     0.000178 
 C    -1.845696    -0.987690     0.000040 
 C    -0.827852    -0.031135     0.000383 
 C    -1.141255     1.353010    -0.000218 
 O    -0.207796     2.295770     0.000008 
 C    -2.508651     1.682000    -0.000701 
 C    -3.500007     0.689466    -0.000670 
 C    -3.206497    -0.675624    -0.000463 
 H    -3.973538    -1.441007    -0.000624 
 H    -4.542487     1.000887    -0.001077 
 H    -2.779867     2.732908    -0.001070 
 H     4.612903     1.369165    -0.000318 
 H     0.720290     1.808080     0.000867 
 
 
 
60 
 
ProD5TS 
 
C     1.443039     0.000000     1.932871 
N     2.694185    -0.047871     1.107438 
C     3.797090     0.020118     1.622302 
C     5.271532    -0.033664     0.307483 
O     5.962196    -0.062548    -0.376524 
C     5.449521    -0.206269    -1.181356 
C     2.569017    -0.182739    -0.218770 
 H     1.612240    -0.204424    -0.450488 
 C    -0.685984     1.272605     2.003378 
 C    -0.559777     1.285488     3.548972 
 C     1.537690     0.026681     3.273734 
 C     0.240203     0.041098     4.040995 
 C     0.436788     0.062620     5.557575 
 C    -0.556101    -1.220495     3.584993 
 C    -0.700276    -1.247414     2.039983 
 H    -1.548329     1.274787     4.022224 
 H    -0.208052     2.147642     1.554721 
 H    -1.739101     1.286252     1.703170 
 H    -0.247525    -2.147420     1.613600 
 H    -1.758044    -1.246004     1.755024 
 H    -0.040983    -2.118326     3.939045 
 H    -1.540479    -1.207161     4.066599 
 H    -0.526956     0.073316     6.077637 
 H     0.991137    -0.818970     5.896302 
 H     0.996132     0.950900     5.869487 
 H     2.506727     0.027442     3.763974 
 C    -1.212584    -0.264586    -0.716933 
 O    -1.027845     0.090633    -2.037615 
 C    -0.937868     1.496431    -2.262335 
 H    -0.875034     1.634010    -3.342554 
 H    -0.048061     1.923614    -1.788434 
 H    -1.831280     2.013371    -1.883793 
 H    -2.037835     0.296389    -0.250096 
 H    -0.055270     2.195496     3.887043 
 H    -1.432481    -1.337140    -0.70746 
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 الحسابيت بالطزق هوكسيسليلأ هي هبخكزة هساعذة أدويت حصوين
 
  وعذ هحوذ صالح حوراًيإعذاد: 
 
 إشزاف: البزوفيسور رفيق قزهاى
 
 
 الولخص 
انًزاق‏انًّش‏وقهت‏انثباث‏يًا‏‏:تىاخه‏انعقاقٍش‏والأدوٌت‏انًضادة‏نهبكتٍشٌا‏انتً‏ٌتى‏تسىٌقها‏انعذٌذ‏يٍ‏انًشاكم‏يثم
انتً ‏تساهى ‏فً ‏حّم ‏يثم ‏تهك‏‏الأدوٌتطهٍعت ‏ٌؤدي ‏إنى ‏عذو ‏ايتثال ‏انًشٌض‏نهعلاج. ‏وقذ ‏تى ‏إٌداد ‏تكُىنىخٍا ‏
طهٍعت ‏انذواء ‏ل‏‏انًشاكم. ‏وبُاء ‏عهى ‏حساباث ‏َظشٌت ‏انكثافت ‏انىظٍفٍت ‏انتً ‏تى ‏تقذًٌها ‏سابقا،ً ‏فقذ ‏تى ‏تصًٍى
صانت‏انًزاق‏ان ًُ ّش ‏انزي‏تتسى‏به‏الأدوٌت‏الأونٍت‏ٌُتح‏عٍ‏تبذٌم‏قذسة‏انذواء‏إقذ‏بأٌ‏.‏ويٍ‏ان ًُ عت5-1يىكسٍهٍٍ‏الأ
‏عهى‏انتفاعم‏يع‏يستقبلاث‏انًزاق‏انًّش.
‏
 )p ,d( G13-6 PYL3Bعهى‏يستىٌاث‏يختهفت‏يٍ‏ latibro ralucelom TFDباستعًال‏انطشق‏انحسابٍت‏
كاسبً‏واستغلال‏‏الإَضٌى‏ل‏انعانى‏‏فً‏ًَىرج‏ًٍ‏خضئًنعًهٍت‏َقم‏انبشوتىٌ‏ض‏)p ,d( G+113/PYL3Bو
فً‏‏يٍ‏دوٌ‏طعى‏يش‏و‏رو‏فعانٍت‏عانٍت ‏نهىصىل‏إنى‏انذوسة ‏انذيىٌت‏يىكسٍسهٍطهٍعت ‏الأنتصًٍى ‏‏انًُىرجاهز
‏.اندسى‏يقاسَت‏يع‏انذواء‏الأو
انًسافت‏بٍٍ‏‏انذافعت‏هًواٌ‏انقىة‏َقم‏انبشوتىٌ‏بعًهٍت‏‏شٌتأث‏يىكسٍسهٍل‏الأنقذ‏وخذ‏أٌ‏يعذل‏انتحىٌم‏انذاخهً‏
انًشكضٌٍ‏انًتفاعهٍٍ‏و‏انضاوٌت‏بٍُهى‏و‏يعذل‏حصىل‏انتفاعم‏ٌتُاسب‏بشكم‏خطً‏يع‏كم‏يُهًا. ‏وبانتانً‏فاٌ‏
إنى‏انذواء‏الأو‏ًٌكٍ‏أٌ‏ٌدذول‏بالاعتًاد‏عهى‏طبٍعت‏انشابظ‏انزي‏‏ الايىكسٍسهٍطهٍعت‏ل‏يعذل‏انتحىٌم‏انذاخهً‏
‏.انذواءطهٍعت‏‏‏ٌتى‏سبطه‏بانذواء‏نعًم
‏
